Afya Limited AFYA 深 滬
等待開盤 04-01 09:30:00 美东时间
14.87
0.000
0.00%
華盛通- 最 高--
- 今 開--
- 成交量 0股
- 最 低 --
- 昨 收 14.87
- 總市值 13.36亿
- 52周最高 19.244
- 市盈率 靜 10.08
- 換手率 0.00%
- 52周最低 12.344
- 委 比 0.00%
- 總股本 8986.77万
- 歷史最高 33.9819
- 量 比 0
- 振 幅 0.00%
- 歷史最低 7.8419
- 每 手 1
- 風險率 1.65%
個股概要
財務分析
公司資料
相關新聞
分紅派息
- 分時圖
- 日k
- 周k
- 月k
相關新聞
更多Afya declares $3.446 dividend
Afya (AFYA) declares $3.446/share dividend. Payable April 6; for shareholders of record March 25; ex-div March 25. See AFYA Dividend Scorecard, Yield Chart, & Dividend Growth. More on Afya Afya Limite...
03-13 22:36
Reported earlier, Afya Sees FY2026 Sales $731.710M-$759.496M vs $763.950M Est
Afya (NASDAQ:AFYA) sees FY2026 sales of $731.710 million-$759.496 million vs $763.950 million analyst estimate.
03-13 16:05
Afya Q4 Adj. EPS $0.42 Beats $0.37 Estimate, Sales $169.130M Miss $177.120M Estimate
Afya (NASDAQ:AFYA) reported quarterly earnings of $0.42 per share which beat the analyst consensus estimate of $0.37 by 13.51 percent. This is a 16.67 percent increase over earnings of $0.36 per share from the same
03-13 15:04
Afya Non-GAAP EPS of R$2.25, revenue of R$912.99M; gives FY26 outlook
Afya press release (AFYA): Q4 Non-GAAP EPS of R$2.25. Revenue of R$912.99M (+7.5% Y/Y). 4Q25 Adjusted EBITDA increased 6.1% YoY, reaching R$388.5 million, with an Adjusted EBITDA Margin of 42.6%. Ope...
03-13 12:45
BRIEF-Afya Limited Announces Fourth Quarter And Twelve Months 2025 Financial Results
BRIEF-Afya Limited Announces Fourth Quarter And Twelve Months 2025 Financial Results March 12 (Reuters) - Afya Ltd AFYA.O : AFYA LIMITED ANNOUNCES FOURTH QUARTER AND TWELVE MONTHS 2025 FINANCIAL RESULTS AFYA LTD: 4Q25 REVENUE INCREASED 7.5% YOY TO R$913.0 MILLION AFYA LTD - FOR FY 2026 WE EXPECT REV
03-13 08:24
美股大行评级 | 潜在涨幅243.25%！泰利克斯制药获花旗升目标价至22.5美元，维持"买入"评级
今日重点评级关注：花旗：维持Telix Pharmaceuticals"买入"评级，目标价从22美元升至22.5美元；摩根士丹利：维持Vir Biotechnology"超配"评级，目标价从20美元升至24美元
02-25 11:03
Dollar General To Rally More Than 11%? Here Are 10 Top Analyst Forecasts For Tuesday
Top Wall Street analysts changed their outlook on these top names. For a comple...
02-24 21:40
B of A Securities Downgrades Afya to Neutral, Lowers Price Target to $17
B of A Securities analyst Roberto Otero downgrades Afya (NASDAQ:AFYA) from Buy to Neutral and lowers the price target from $22 to $17.
02-24 19:10
Morgan Stanley Downgrades Afya to Underweight, Lowers Price Target to $16
Morgan Stanley analyst Mauricio Cepeda downgrades Afya (NASDAQ:AFYA) from Equal-Weight to Underweight and lowers the price target from $17.5 to $16.
02-13 19:28
美股大行评级 | 潜在上涨空间31.6%！巴克莱上调台积电目标价至450美元；第一地平线全国银行获5家机构上调目标价
今日重点评级关注：Guggenheim：维持MBX Biosciences"买入"评级，目标价从77美元升至88美元；摩根士丹利：维持DraftKings"超配"评级，目标价从50美元升至53美元
01-20 10:26
